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LETTERS TO THE EDITOR
Regarding “Transcervical carotid stenting with
carotid artery flow reversal: 3-year follow-up of 103
stents”
We read with interest the paper by Criado et al1 and were
impressed with their innovative approach to intervention for ca-
rotid disease. However, a number of difficulties were highlighted
at our recent journal club review of the study.
First, the authors advocate their method as suitable for pa-
tients at high risk for general anesthesia. Carotid endarterectomy is
routinely performed under local anesthesia in many centers, and
95% of all carotid endarterectomies in our institution are per-
formed successfully under local anesthesia compared with 70%
reported in this series.
Second, although the authors present an impressive series with
a low stroke rate, their method is still associated with a considerable
rate of presumably embolic transient neurologic events (transient
ischemic attacks and unresponsive episodes) in this low-risk group
(64% asymptomatic). This is particularly disappointing because the
authors advocate their technique on the basis of a reduction of
periprocedural embolization. In this context, for the reported
series to demonstrate any advantage over standard protection
devices, some form of imaging or Doppler studies, or both, would
have been necessary.
Finally, no comparison with previous studies was made for the
non-neurologic complications. We were particularly alarmed by 24
patients (23%) developing bradycardia or hypotension (2 with
asystole) requiring pharmacologic intervention.
We agree that further investigation of alternative techniques
and technologies are required to improve the results of carotid
stenting. However, to conclude that this technique compares
favorably with stenting using distal filter protection is premature
on the basis of this series, which further emphasizes the difficulties
and complexities of carotid intervention.
Ian D. Hunter, MBBS, MRCS
Michael A. Murphy, MD, FRCS
Department of Vascular Surgery
John Radcliffe Hospital
Oxford, United Kingdom
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The authors declined to reply to this letter.
–Eds.
Regarding “A comparison of percutaneous
transluminal angioplasty versus amputation for
critical limb ischemia in patients unsuitable for
open surgery”
In the article by Taylor et al,1 the authors reported that almost
70% of the patient population described in their study was affected
by diabetes. We were rather surprised by the high percentage of
amputations in the case histories (700/2400, 29.2%), as well as by
the high percentage of the 30-day mortality in the group of
amputated patients and, most of all, in the peripheral transluminal
angioplasty (PTA) group. These data are quite in contrast with
data from our experience.2 This series consisted of very elderly
patients. The percentage of patients aged 80 years and older who
underwent PTA was almost the double of that of patients who
underwent amputation: 36.6% vs 21.8%.
We found the hypothesis that age can be the greatest prog-
nostic independent factor fascinating, although the model has
been adjusted for age, race, and diabetes mellitus. If this were true
and the model has been adjusted for age, race, and diabetes
mellitus, these data would hardly seem to meet the criteria for
compliance to “good clinical practice” and, consequently, we
believe that the authors’ conclusions would hardly be acceptable.
Ezio Faglia, MD
Giacomo Clerici, MD
IRCCS Policlinico Multimedica
Milan, Italy
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Reply
This letter is written in response to both the Invited Commen-
tary by Joseph L. Mills, MD and a recent letter sent to the Journal
concerning our article entitled “A comparison of percutaneous
transluminal angioplasty versus amputation for critical limb isch-
emia in patients unsuitable for open surgery”.1 In this article, we
attempted to address the utility of percutaneous transluminal
angioplasty in chronically ill patients with critical limb ischemia
who, because of their overall medical condition, were not candi-
dates for open bypass. Our retrospective cohort comparison found
that amputation yielded similar functional outcomes at 1 year and
better overall survival outcomes than angioplasty. Based on this,
we concluded angioplasty is probably not beneficial. Apparently,
our conclusions have not been universally accepted. At present it
seems our critics believe we have unfairly maligned angioplasty and
have cited the heterogeneity of our cohort groups as the primary
reason.
By way of background, we originally examined the 131 pa-
tients who underwent percutaneous transluminal angioplasty
(PTA) for limb salvage alone, and found our results to be both
bland and inconclusive (63% 12 month limb salvage, 29% survival
at 24 months, 60.2% maintenance of ambulation at 24 months,
and 60.5% maintenance of independent living status at 24
months). Therefore, as a general reference for comparison, we
examined all amputees who met our definition of “unsuitable for
surgery” during the same time period. (Please note, our amputa-
tion registry includes all patients amputated, not just patients
amputated who failed revascularization as incorrectly assumed by
our critics). Indeed, heterogeneity of demographics between the
two groups was notable. However, when adjusting for age, race,
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